Simcha Therapeutics’ $40 Million Series B Financing

Martina Bellini
Tagged:

Wilson Sonsini Goodrich & Rosati advised SR One on the deal.Simcha Therapeutics, a biotechnology company developing cytokine-based cancer immunotherapies, announced the closing of a $40 million…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now